SUNY

The company hopes to develop saliva-based RNA assays for concussion, Parkinson's disease and autism using biomarkers discovered by its two academic partners.

Speakers at the Association of Biomolecular Resource Facilities annual meeting discussed their approaches for single-cell genomic studies of tumor and immune cells.

Gen-Probe (Hologic) has also been awarded

Bio-Rad Laboratories has been awarded US Patent No. 8,236,504, "Systems and methods for fluorescence detection with a movable detection module."
Igor Kordunsky, Jeffrey Goldman, and Michael Finney are named as inventors on the patent.

IP Roundup

Premium

Autogenomics, Illumina, State University of New York, Rosetta Genomics, Aviva Biosciences, Tsinghua University, CapitalBio

The university will pilot a summer elective course on genetics that includes several precautionary measures to ensure that students don't feel coerced to participate. The incorporation of this course as a permanent program will depend on the success of this pilot, the university said.

The suit is the second filed by the plaintiffs this year against a generic drug manufacturer for allegedly infringing patents protecting Galderma's rosacea treatment Oracea by filing an ANDA for a generic version of the drug.

An influx of managerial and scientific talent due to layoffs from financial institutions and pharmaceutical companies, coupled with new incubator space, could help build a university-fueled life sciences cluster in the New York region, said tech-transfer experts at last week's New York Biotechnology Association meeting.

Luminex will pay $4.35 million to settle a dispute filed by SUNY in December 2007, which alleged breach of contract.

A total of six facilities comprising more than 2 million square feet are in New York's pipeline of life-sci space, according to the panelists who spoke at the New York Biotechnology Association's annual meeting this week.

Pages

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.